Ray Dalio's position in Jazz Pharmaceuticals plc is currently worth $18.9 Million. That's 0.09% of their equity portfolio (160th largest holding). The first Jazz Pharmaceuticals plc trade was made in Q4 2020. Since then Ray Dalio bought shares eight more times and sold shares on five occasions. The investor's estimated purchase price is $24 Million, resulting in a loss of 21%.